Ardelyx reported $-12.42M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 1.36B 775M Sep/2026
Amgen USD 4.68B 65M Sep/2026
Ardelyx USD -12.42M 20.37M Jun/2026
aTyr Pharma USD -104K 24K Jun/2026
Corcept Therapeutics USD 114.72M 73.42M Sep/2026
Curis USD -11.52M 3.64M Mar/2026
Sanofi EUR 2.38B 115M Jun/2026
TG Therapeutics USD 85.9M 64.22M Sep/2026
United Therapeutics USD 241.3M 89.5M Sep/2026